Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Gerard

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Proceedings of the Mine Medical Officers' Association|May 1, 1973
Calcaneal fracturesC L Gerard
Proceedings of the Mine Medical Officers' Association|May 1, 1973
Acute cholecystitisC L Gerard
Developmental Medicine and Child Neurology|February 1, 1992
Chiari malformation type I in a child with velopharyngeal insufficiencyC L Gerard, M Dugas, P Narcy, et al.
Cancer Treatment Reviews|October 16, 2021
Turning tumors from cold to inflamed to improve immunotherapy responseC L Gerard, J Delyon, A Wicky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanomaC N Owen, X Bai, T Quah, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Proceedings of the Mine Medical Officers' Association|May 1, 1973
Calcaneal fracturesC L Gerard
Proceedings of the Mine Medical Officers' Association|May 1, 1973
Acute cholecystitisC L Gerard
Developmental Medicine and Child Neurology|February 1, 1992
Chiari malformation type I in a child with velopharyngeal insufficiencyC L Gerard, M Dugas, P Narcy, et al.
Cancer Treatment Reviews|October 16, 2021
Turning tumors from cold to inflamed to improve immunotherapy responseC L Gerard, J Delyon, A Wicky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanomaC N Owen, X Bai, T Quah, et al.
Pageof 1